HYDROMOX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydromox, and when can generic versions of Hydromox launch?
Hydromox is a drug marketed by Lederle and is included in two NDAs.
The generic ingredient in HYDROMOX is quinethazone; reserpine. Additional details are available on the quinethazone; reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROMOX?
- What are the global sales for HYDROMOX?
- What is Average Wholesale Price for HYDROMOX?
Summary for HYDROMOX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Patent Applications: | 2,699 |
| DailyMed Link: | HYDROMOX at DailyMed |
US Patents and Regulatory Information for HYDROMOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | HYDROMOX | quinethazone | TABLET;ORAL | 013264-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lederle | HYDROMOX R | quinethazone; reserpine | TABLET;ORAL | 013927-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
